Summit Therapeutics (SMMT) total assets

Total assets · fiscal 2025
$751.18M

Summit Therapeutics (SMMT) had total assets of $751.18M at the end of fiscal 2025 (December 31, 2025). That is 72.5% higher than the $435.56M of fiscal 2024. Figures as of 18 Nov 2026, 06:51 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$751.18M
Change on fiscal 2024
+72.5%
Growth, 5 years
+48.9% a year
Highest on record
$751.18Mfiscal 2025
Lowest on record
$102.50Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Summit Therapeutics total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 48.9% a year. Across the 6 fiscal years on record (2020–2025), the highest was $751.18M in fiscal 2025 and the lowest $102.50M in fiscal 2020.

History · 6 fiscal years

Total assets by fiscal year

Summit Therapeutics total assets, year by year

Summit Therapeutics (SMMT) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$751.18M 72.5% up
2024$435.56M 114.6% up
2023$202.95M 69.4% down
2022$664.17M 485.8% up
2021$113.37M 10.6% up
2020$102.50M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Summit Therapeutics and comparable companies
CompanyTotal assetsFiscal year
BridgeBio Pharma BBIO$936.03M2025
Summit Therapeutics SMMT$751.18M2025
Glaukos GKOS$893.49M2025
Encompass Health EHC$7.09B2025
BrightSpring Health Services BTSG$6.41B2025
Baxter International BAX$20.06B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SMMT

Summit Therapeutics, figure by figure

Summit Therapeutics (SMMT) overview: price, valuation and scorecardAll health care companies by market value

Summit Therapeutics total assets: questions and answers

How large are Summit Therapeutics's total assets?

Summit Therapeutics (SMMT) had total assets of $751.18M at the end of fiscal 2025 (December 31, 2025). That is 72.5% higher than the $435.56M of fiscal 2024.

What is the growth rate of Summit Therapeutics's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 48.9% a year.

What are the highest and lowest total assets figures on record for Summit Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was $751.18M in fiscal 2025 and the lowest $102.50M in fiscal 2020.

How is Summit Therapeutics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Summit Therapeutics (SMMT) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/SMMT/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.